Posts in tag

medicinal cannabis


The TGA has handed down more than $23K in fines relating to unlawful advertising of medicinal cannabis to treat cancer, and of homeopathy for COVID-19 The Therapeutic Goods Administration made …

Debbie Rigby takes a look at the latest in research news Integration of non-dispensing pharmacists into primary healthcare services This umbrella review and narrative synthesis suggest that the integration of …

Debbie Rigby rounds up the latest in research news Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community Interim analyses from the PRINCIPLE trial …

With certain medicinal cannabis products now S3 but not yet available in pharmacy, the TGA is warning about the risks of buying online On Monday the Therapeutic Goods Administration warned …

Debbie Rigby rounds up the latest in research news Multiple short courses of corticosteroids in children Short courses of oral steroids (less than two weeks) in children are very unlikely …

Ben Basger takes a look at some issues around medicinal cannabis, including the fact that data is still very much emerging Speaking to our Professor of Pain Management and Palliative …

There’s been a lot happening in pharmacy this week, with COVID-19 vaccine and scheduling news coming to the fore Pharmacist and ALP MP for Dobell Emma McBride called in Parliament …

A medicinal cannabis company has entered an exclusive deal with Chemist Warehouse, as low-dose cannabidiol goes S3 Cannatrek Limited made the announcement on Wednesday, saying that it will supply the …

Despite the accumulating body of scientific knowledge about, and the growing demand for access to products derived from medicinal cannabis, there is still an absence of the clinical trial data …

The TGA has announced a final decision to downschedule certain low dose cannabidiol (CBD) preparations These preparations are set to be downscheduled from Schedule 4 (Prescription Medicine) to Schedule 3 …

Insurance plan means pharmacy owner can’t use his own pharmacy; technician struck off after falsely claiming to be disaster victim; NZ pharmacies under scrutiny over cannabis prices London, England: A …

Stakeholders have welcomed an interim TGA decision to downschedule low-dose cannabidiol to S3 – but the peak pharmacist body warns that evidence and therapeutic purpose are key The TGA has …